Leads Pharma Professional Services Sales 
Clarivate
JANUARY 23, 2024
forecast peak sales per asset versus the cost of developing an asset or an output measure such as the number of global first world launches). In addition, R&D productivity analyses are in some way associated with actual or future launches or a consequence of the launch, such as resulting sales.
PharmaKinnex
SEPTEMBER 28, 2022
Everyone knows that over the next few weeks and months, businesses in the pharma marketing industry will meet to discuss next year’s budget. Is it possible to increase product revenues, contact more leads, extend product life cycles, and make work easier? Industry Analysis: Remote Inside Sales Are The Future.
Expert insights. Personalized for you.
52 
Let's personalize your content